General Information of Drug Off-Target (DOT) (ID: OT2GX84M)

DOT Name GDNF-inducible zinc finger protein 1 (GZF1)
Synonyms Zinc finger and BTB domain-containing protein 23; Zinc finger protein 336
Gene Name GZF1
Related Disease
Joint laxity, short stature, and myopia ( )
Larsen syndrome ( )
UniProt ID
GZF1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00651 ; PF00096 ; PF13912
Sequence
MESGAVLLESKSSPFNLLHEMHELRLLGHLCDVTVSVEYQGVRKDFMAHKAVLAATSKFF
KEVFLNEKSVDGTRTNVYLNEVQVADFASFLEFVYTAKVQVEEDRVQRMLEVAEKLKCLD
LSETCFQLKKQMLESVLLELQNFSESQEVEVSSGSQVSAAPAPRASVATDGPHPSGLTDS
LDYPGERASNGMSSDLPPKKSKDKLDKKKEVVKPPYPKIRRASGRLAGRKVFVEIPKKKY
TRRLREQQKTAEGDVGDYRCPQDQSPDRVGTEMEQVSKNEGCQAGAELEELSKKAGPEEE
EEEEEEDEEGEKKKSNFKCSICEKAFLYEKSFLKHSKHRHGVATEVVYRCDTCGQTFANR
CNLKSHQRHVHSSERHFPCELCGKKFKRKKDVKRHVLQVHEGGGERHRCGQCGKGLSSKT
ALRLHERTHTGDRPYGCTECGARFSQPSALKTHMRIHTGEKPFVCDECGARFTQNHMLIY
HKRCHTGERPFMCETCGKSFASKEYLKHHNRIHTGSKPFKCEVCFRTFAQRNSLYQHIKV
HTGERPYCCDQCGKQFTQLNALQRHRRIHTGERPFMCNACGRTFTDKSTLRRHTSIHDKN
TPWKSFLVIVDGSPKNDDGHKTEQPDEEYVSSKLSDKLLSFAENGHFHNLAAVQDTVPTM
QENSSADTACKADDSVVSQDTLLATTISELSELTPQTDSMPTQLHSLSNME
Function Transcriptional repressor that binds the GZF1 responsive element (GRE) (consensus: 5'-TGCGCN[TG][CA]TATA-3'). May be regulating VSX2/HOX10 expression.
Tissue Specificity Expressed in adult brain, heart, skeletal muscle, kidney and liver. Also detected in fetal brain and kidney, and at lower levels in fetal lung and liver.

Molecular Interaction Atlas (MIA) of This DOT

2 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Joint laxity, short stature, and myopia DISYDDUS Strong Autosomal recessive [1]
Larsen syndrome DISDRPMA Strong Autosomal recessive [2]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
12 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the expression of GDNF-inducible zinc finger protein 1 (GZF1). [3]
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of GDNF-inducible zinc finger protein 1 (GZF1). [4]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of GDNF-inducible zinc finger protein 1 (GZF1). [5]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate increases the expression of GDNF-inducible zinc finger protein 1 (GZF1). [6]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of GDNF-inducible zinc finger protein 1 (GZF1). [7]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide affects the expression of GDNF-inducible zinc finger protein 1 (GZF1). [8]
Marinol DM70IK5 Approved Marinol decreases the expression of GDNF-inducible zinc finger protein 1 (GZF1). [9]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of GDNF-inducible zinc finger protein 1 (GZF1). [10]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the expression of GDNF-inducible zinc finger protein 1 (GZF1). [11]
Leflunomide DMR8ONJ Phase 1 Trial Leflunomide increases the expression of GDNF-inducible zinc finger protein 1 (GZF1). [12]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of GDNF-inducible zinc finger protein 1 (GZF1). [13]
Formaldehyde DM7Q6M0 Investigative Formaldehyde increases the expression of GDNF-inducible zinc finger protein 1 (GZF1). [15]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
PMID28870136-Compound-52 DMFDERP Patented PMID28870136-Compound-52 affects the phosphorylation of GDNF-inducible zinc finger protein 1 (GZF1). [14]
------------------------------------------------------------------------------------

References

1 Novel GZF1 pathogenic variants identified in two Chinese patients with Larsen syndrome. Clin Genet. 2021 Feb;99(2):281-285. doi: 10.1111/cge.13856. Epub 2020 Oct 10.
2 GZF1 Mutations Expand the Genetic Heterogeneity of Larsen Syndrome. Am J Hum Genet. 2017 May 4;100(5):831-836. doi: 10.1016/j.ajhg.2017.04.008.
3 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
4 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
5 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
6 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
7 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
8 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
9 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
10 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
11 New insights into BaP-induced toxicity: role of major metabolites in transcriptomics and contribution to hepatocarcinogenesis. Arch Toxicol. 2016 Jun;90(6):1449-58.
12 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
13 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
14 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
15 In vitro effects of aldehydes present in tobacco smoke on gene expression in human lung alveolar epithelial cells. Toxicol In Vitro. 2013 Apr;27(3):1072-81.